Characterization of plasmids encoding CMY-2 AmpC β-lactamases from Escherichia coli in Canadian intensive care units

Diagnostic Microbiology and Infectious Disease

Volumn 65, Issue 4, 2009, Pages 379-383

  Baudry, Patricia J ^a,b   Mataseje, Laura ^a,c   Zhanel, George G ^a,b   Hoban, Daryl J ^a,b   Mulvey, Michael R ^a,c  

^a UNIVERSITY OF MANITOBA   (Canada)

^b HEALTH SCIENCES CENTRE   (Canada)

^c PUBLIC HEALTH AGENCY OF CANADA   (Canada)

Author keywords

CMY 2 AmpC Lactamase; Escherichia coli; Plasmids

Indexed keywords

AMPICILLIN; BETA LACTAMASE AMPC; CARBAPENEM DERIVATIVE; CEFAZOLIN; CEFEPIME; CEFOXITIN; CEFTRIAXONE; CIPROFLOXACIN; COTRIMOXAZOLE; DOXYCYCLINE; ERTAPENEM; GENTAMICIN; LEVOFLOXACIN; MEROPENEM; PIPERACILLIN PLUS TAZOBACTAM; QUINOLINE DERIVED ANTIINFECTIVE AGENT; TIGECYCLINE;

ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL STRAIN; BACTERIAL TRANSMISSION; BACTERIAL VIRULENCE; BACTERIUM ISOLATE; BROTH DILUTION; CANADA; CLONAL SPECIES; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTION; GENE SEQUENCE; HORIZONTAL GENE TRANSFER; HUMAN; INTENSIVE CARE UNIT; MULTIDRUG RESISTANCE; NONHUMAN; PLASMID; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PULSED FIELD GEL ELECTROPHORESIS; SEQUENCE ANALYSIS; SEQUENCE HOMOLOGY;

BACTERIAL PROTEINS; BACTERIAL TYPING TECHNIQUES; BETA-LACTAMASES; CANADA; CLUSTER ANALYSIS; CROSS INFECTION; DNA FINGERPRINTING; DNA, BACTERIAL; ELECTROPHORESIS, GEL, PULSED-FIELD; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTIONS; GENOTYPE; HUMANS; INTENSIVE CARE UNITS; MICROBIAL SENSITIVITY TESTS; PLASMIDS;

EID: 71549149356     PISSN: 07328893     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.diagmicrobio.2009.08.011     Document Type: Article

References (22)

1. Baudry P.J., Nichol K., DeCorby M., Mataseje L., Mulvey M.R., Hoban D.J., and Zhanel G.G. Comparison of antimicrobial resistance profiles among extended-spectrum-beta-lactamase-producing and acquired AmpC beta-lactamase-producing Escherichia coli isolates from Canadian intensive care units. Antimicrob. Agents Chemother. 52 (2008) 1846-1849
2. Boyd D.A., Tyler S., Christianson S., McGeer A., Muller M.P., Willey B.M., Bryce E., Gardam M., Nordmann P., and Mulvey M.R. Complete nucleotide sequence of a 92-kilobase plasmid harboring the CTX-M-15 extended-spectrum beta-lactamase involved in an outbreak in long-term-care facilities in Toronto, Canada. Antimicrob. Agents Chemother. 48 (2004) 3758-3764
3. Brantl S. Plasmid replication control by antisense RNA. In: Funnell B.a.P.G. (Ed). Plasmid Biology (2004), American Society for Microbiology, Washington, D.C. 57
4. Carattoli A. Resistance plasmid families in Enterobacteriaceae. Antimicrob. Agents Chemother. 53 (2009) 2227-2238
5. Carattoli A., Bertini A., Villa L., Falbo V., Hopkins K.L., and Threlfall E.J. Identification of plasmids by PCR-based replicon typing. J. Microbiol. Methods. 63 (2005) 219-228
6. Carattoli A., Miriagou V., Bertini A., Loli A., Colinon C., Villa L., Whichard J.M., and Rossolini G.M. Replicon typing of plasmids encoding resistance to newer beta-lactams. Emerg. Infect. Dis. 12 (2006) 1145-1148
7. Clermont O., Bonacorsi S., and Bingen E. Rapid and simple determination of the Escherichia coli phylogenetic group. Appl. Environ. Microbiol. 66 (2000) 4555-4558
8. Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing: 16th informational supplement document (M100-S16) (2006), CLSI, Wayne, PA
9. da Silva Dias R.C., Borges-Neto A.A., D'Almeida Ferraiuoli G.I., de-Oliveira M.P., Riley L.W., and Moreira B.M. Prevalence of AmpC and other beta-lactamases in enterobacteria at a large urban university hospital in Brazil. Diagn. Microbiol. Infect. Dis 60 (2008) 79-87
10. Deshpande L.M., Jones R.N., Fritsche T.R., and Sader H.S. Occurrence of plasmidic AmpC type beta-lactamase-mediated resistance in Escherichia coli: report from the SENTRY Antimicrobial Surveillance Program (North America, 2004). Int. J. Antimicrob. Agents 28 (2006) 578-581
11. Goyanes M.J., Cercenado E., Insa R., Morente A., Alcala L., and Bouza E. High rates of antimicrobial co-resistance among Enterobacteriaceae: comparative analysis between clinical isolates resistant and susceptible to third-generation cephalosporins. Rev. Esp. Quimioter. 20 (2007) 216-221
12. Hopkins K.L., Liebana E., Villa L., Batchelor M., Threlfall E.J., and Carattoli A. Replicon typing of plasmids carrying CTX-M or CMY beta-lactamases circulating among Salmonella and Escherichia coli isolates. Antimicrob. Agents Chemother. 50 (2006) 3203-3206
13. Jacoby G.A. AmpC beta-lactamases. Clin. Microbiol. Rev. 22 (2009) 161-182
14. Mataseje L.F., Neumann N., Crago B., Baudry P., Zhanel G.G., Louie M., and Mulvey M.R. Characterization of cefoxitin-resistant Escherichia coli isolated from recreational beaches and private drinking water in Canada between 2004 and 2006. Antimicrob. Agents Chemother 53 (2009) 3126-3130
15. Mulvey M.R., Bryce E., Boyd D., Ofner-Agostini M., Christianson S., Simor A.E., and Paton S. Ambler class A extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella spp. in Canadian hospitals. Antimicrob. Agents Chemother. 48 (2004) 1204-1214
16. Mulvey M.R., Bryce E., Boyd D.A., Ofner-Agostini M., Land A.M., Simor A.E., and Paton S. Molecular characterization of cefoxitin-resistant Escherichia coli from Canadian hospitals. Antimicrob. Agents Chemother. 49 (2005) 358-365
17. Osborn A.M., da Silva Tatley F.M., Steyn L.M., Pickup R.W., and Saunders J.R. Mosaic plasmids and mosaic replicons: evolutionary lessons from the analysis of genetic diversity in IncFII-related replicons. Microbiology 146 (2000) 2267-2275
18. Perez-Perez F.J., and Hanson N.D. Detection of plasmid-mediated AmpC beta-lactamase genes in clinical isolates by using multiplex PCR. J. Clin. Microbiol. 40 (2002) 2153-2162
19. Philippon A., Arlet G., and Jacoby G.A. Plasmid-determined AmpC-type beta-lactamases. Antimicrob. Agents Chemother. 46 (2002) 1-11
20. Pitout J.D., Gregson D.B., Church D.L., and Laupland K.B. Population-based laboratory surveillance for AmpC beta-lactamase-producing Escherichia coli, Calgary. Emerg. Infect. Dis. 13 (2007) 443-448
21. Potz N.A., Hope R., Warner M., Johnson A.P., and Livermore D.M. Prevalence and mechanisms of cephalosporin resistance in Enterobacteriaceae in London and South-East England. J. Antimicrob. Chemother. 58 (2006) 320-326
22. Zhanel G.G., DeCorby M., Laing N., Weshnoweski B., Vashisht R., Tailor F., Nichol K.A., Wierzbowski A., Baudry P.J., Karlowsky J.A., et al. Antimicrobial-resistant pathogens in intensive care units in Canada: results of the Canadian National Intensive Care Unit (CAN-ICU) study, 2005-2006. Antimicrob. Agents Chemother. 52 (2008) 1430-1437